Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor in the prevention of chemotherapy-induced neutropenia in patients with breast cancer.

被引：0
|
作者：
Chong, Xiaoyu
Zhu, Xiaoli
Li, Xuejuan
Gao, Lingna
Ma, Hongfang
Chong, Baogui
机构：
[1] Hengshui Peoples Hosp, Hengshui, Peoples R China
[2] CSPC Baike Shandong Biopharmaceut Co Ltd, Shijiazhuang, Hebei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12515
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of autoimmune neutropenia with recombinant human granulocyte colony-stimulating factor
    G. Carulli
    Annals of Hematology, 1998, 76 : 93 - 94
  • [32] Clinical implications, safety, efficacy of recombinant human Granulocyte Colony-Stimulating Factors and pegylated equivalent
    Bolis, Silvia
    Cocorocchio, Emilia
    Corti, Consuelo
    Ferreri, Andres J. M.
    Frungillo, Niccolo
    Grillo, Giovanni
    Omodeo, Emanuela Sale
    Tedeschi, Lucilla
    Zilioli, Vittorio Ruggero
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2013, 10 (04):
  • [33] EFFECT OF GRANULOCYTE-COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED NEUTROPENIA IN CHILDREN WITH CANCER
    KALMANTI, M
    LYDAKI, E
    DIMITRIOU, H
    KALMANTIS, T
    VLACHONICOLIS, I
    KAMBOURAKIS, A
    ZIOGA, I
    BOLONAKI, I
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (02) : 147 - 155
  • [34] EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA IN PATIENTS WITH CONGENITAL AGRANULOCYTOSIS
    BONILLA, MA
    GILLIO, AP
    RUGGEIRO, M
    KERNAN, NA
    BROCHSTEIN, JA
    ABBOUD, M
    FUMAGALLI, L
    VINCENT, M
    GABRILOVE, JL
    WELTE, K
    SOUZA, LM
    OREILLY, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (24): : 1574 - 1580
  • [35] Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia
    Liu, Xi-Ting
    Zhao, Yan-Xia
    Jia, Guang-Wei
    Yang, Fan
    Zhang, Chuan-Zhou
    Han, Bing
    Dai, Jian-Hua
    Han, Yue-Qin
    Tang, Bo-Hao
    Yang, Xin-Mei
    Shi, Hai-Yan
    Zhou, Yue
    Sui, Zhong-Guo
    Chen, Jian-Zhong
    van den Anker, Johannes N.
    Zhao, Wei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3292 - 3300
  • [36] Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
    Alshari, Osama
    Al Zu'bi, Yazan O.
    Al Sharie, Ahmed H.
    Wafai, Farouk H.
    Aleshawi, Abdelwahab J.
    Atawneh, Farah H.
    Obeidat, Hasan A.
    Daoud, Majd N.
    Khrais, Mohammad Z.
    Albals, Dima
    Tubaishat, Faize
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 963 - 973
  • [37] Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor
    Harker, LA
    Marzec, UM
    Kelly, AB
    Cheung, E
    Tomer, A
    Nichol, JL
    Hanson, SR
    Stead, RB
    BLOOD, 1997, 89 (01) : 155 - 165
  • [38] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING CHEMOTHERAPY FOR UROGENITAL CANCER
    ASO, Y
    AKAZA, H
    JOURNAL OF UROLOGY, 1992, 147 (04): : 1060 - 1064
  • [39] A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.
    Liu, Lihong
    Wu, Lili
    Huang, Chen
    Zhao, Guimin
    Ma, Guangyu
    Gao, Yuhuan
    Diao, Lanping
    Yao, Yingzhen
    Wu, Xiaolin
    Gao, Zhe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] EFFICACY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR CHEMOTHERAPY-INDUCED LEUKOPENIA IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    EGUCHI, K
    KABE, J
    KUDO, S
    MANO, K
    MORINARI, H
    NAKADA, K
    NODA, K
    SAITO, Y
    TANAKA, T
    UZAWA, T
    WATANABE, K
    SAIJO, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (01) : 37 - 43
12345